Correlation Between Resmed and Sartorius Stedim

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Resmed and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Resmed and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Resmed Inc DRC and Sartorius Stedim Biotech, you can compare the effects of market volatilities on Resmed and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Resmed with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of Resmed and Sartorius Stedim.

Diversification Opportunities for Resmed and Sartorius Stedim

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Resmed and Sartorius is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Resmed Inc DRC and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and Resmed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Resmed Inc DRC are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of Resmed i.e., Resmed and Sartorius Stedim go up and down completely randomly.

Pair Corralation between Resmed and Sartorius Stedim

Assuming the 90 days trading horizon Resmed Inc DRC is expected to generate 0.76 times more return on investment than Sartorius Stedim. However, Resmed Inc DRC is 1.31 times less risky than Sartorius Stedim. It trades about 0.08 of its potential returns per unit of risk. Sartorius Stedim Biotech is currently generating about -0.02 per unit of risk. If you would invest  1,524  in Resmed Inc DRC on September 12, 2024 and sell it today you would earn a total of  756.00  from holding Resmed Inc DRC or generate 49.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Resmed Inc DRC  vs.  Sartorius Stedim Biotech

 Performance 
       Timeline  
Resmed Inc DRC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Resmed Inc DRC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Resmed is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Sartorius Stedim Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sartorius Stedim Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Sartorius Stedim is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Resmed and Sartorius Stedim Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Resmed and Sartorius Stedim

The main advantage of trading using opposite Resmed and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Resmed position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.
The idea behind Resmed Inc DRC and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes